csl singapore biostate human coagulation factor viii 250iu/von willebrand factor 500 iu powder for injection vial
csl behring australia pty ltd - factor viii,von willebrand factor -
csl malaysia biostate® human coagulation factor viii 500 iu/von willebrand factor 1000 iu powder for injection vial
csl behring australia pty ltd - factor viii,von willebrand factor -
csl malaysia biostate® human coagulation factor viii 250 iu/von willebrand factor 500 iu powder for injection vial
csl behring australia pty ltd - factor viii,von willebrand factor -
csl hong kong biostate human coagulation factor viii 250iu/von willebrand factor 500iu complex, powder for injection (50 iu/ml f
csl behring australia pty ltd - von willebrand factor, quantity: 500 iu; factor viii, quantity: 250 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl malaysia biostate? human coagulation factor viii 250 iu/von willebrand factor 500 iu powder for injection vial
csl behring australia pty ltd - von willebrand factor, quantity: 500 iu; factor viii, quantity: 250 iu - injection, powder for - excipient ingredients: albumin; sodium chloride; calcium chloride dihydrate; plasma proteins; sodium citrate dihydrate; sucrose; trometamol - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin, (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl malaysia biostate? human coagulation factor viii 500 iu/von willebrand factor 1000 iu powder for injection vial
csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1000 iu - injection, powder for - excipient ingredients: albumin; plasma proteins; calcium chloride dihydrate; sodium chloride; sodium citrate dihydrate; sucrose; trometamol - biostate? is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin, (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl malaysia aleviate human coagulation factor viii 500iu/von willebrand factor 1200iu complex, powder for injection (50iu/ml fviii)
csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: water for injections - aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl malaysia aleviate human coagulation factor viii 250iu/von willebrand factor 600iu complex, powder for injection (50iu/ml fviii)
csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: water for injections - aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl hong kong biostate human coagulation factor viii 250iu/von willebrand factor 500iu complex, powder for injection (50iu/ml fviii)
csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.
csl new zealand biostate human coagulation factor viii, freeze dried 500iu (100iu/ml), powder for injection
csl behring australia pty ltd - factor viii,von willebrand factor -